1994;9:800 804. 327. Ibrahim HN, Jackson S, Connaire J, et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol. 2013;24:320 327. 328. Philipp T, Martinez F, Geiger H, et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant. 2010;25:967 976. 329. Salzberg DJ, Karadsheh FF, Haririan A, et al. Speci c management of anemia and hypertension in renal transplant recipients: in uence of renin-angiotensin system blockade. Am J Nephrol. 2014;39:1 7. 330. Kuypers DR, Neumayer HH, Fritsche L, et al. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study. Transplantation. 2004;78:1204 1211. 331. Sperschneider H, Wagner C, Korn A, et al. Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients. Med Klin (Munich). 1997;92:589 596 [in German]. 332. van der Schaaf MR, Hene RJ, Floor M, et al. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade? Hypertension. 1995;25:77 81. 333. Venkat Raman G, Feehally J, Coates RA, et al. Renal effects of amlodipine in normotensive renal transplant recipients. Nephrol Dial Transplant. 1999;14:384 388. 334. Wilkie ME, Beer JC, Raftery MJ, et al. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients. Transplant Proc. 1993;25:612 615. 335. Makani H, Bangalore S, Romero J, et al. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate a meta- analysis of randomized trials. J Hypertens. 2011;29:1270 1280. 336. Schmidt M, Mans eld KE, Bhaskaran K, et al. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study. BMJ Open. 2017;7:e012818. 337. Amara AB, Sharma A, Alexander JL, et al. 